Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Maher

Showing results (41-50 of 171) with videos related to

Pageof 18
Sort By:
Journal of Medical Genetics|July 1, 2010
Risk of breast cancer in male BRCA2 carriersD G R Evans, I Susnerwala, J Dawson, et al.
The American Journal of Pathology|June 8, 2001
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomasK Kurose, X P Zhou, T Araki, et al.
Human Genetics|October 30, 1999
Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor geneC Cybulski, K Krzystolik, E R Maher, et al.
Human Molecular Genetics|August 1, 1994
Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndromeW Reik, K W Brown, R E Slatter, et al.
Free Radical Research Communications|January 1, 1987
The effect of systemic heparinisation and haemodialysis on plasma octadeca-9,11-dienoic acid (9,11-LA')D G Wickens, J F Griffin, E R Maher, et al.
Human Molecular Genetics|December 1, 1995
Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domainW Reik, K W Brown, H Schneid, et al.
American Journal of Human Genetics|October 3, 1998
An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effectsA R Webster, F M Richards, F E MacRonald, et al.
Genes, Chromosomes & Cancer|June 13, 1998
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesisS C Clifford, A H Prowse, N A Affara, et al.
Ophthalmology|March 18, 1999
A clinical and molecular genetic analysis of solitary ocular angiomaA R Webster, E R Maher, A C Bird, et al.
Journal of Medical Genetics|August 3, 2000
Detailed mapping of a congenital heart disease gene in chromosome 3p25E K Green, M D Priestley, J Waters, et al.
Pageof 18

Showing results (41-50 of 171) with videos related to

Sort By:
Pageof 18
Journal of Medical Genetics|July 1, 2010
Risk of breast cancer in male BRCA2 carriersD G R Evans, I Susnerwala, J Dawson, et al.
The American Journal of Pathology|June 8, 2001
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomasK Kurose, X P Zhou, T Araki, et al.
Human Genetics|October 30, 1999
Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor geneC Cybulski, K Krzystolik, E R Maher, et al.
Human Molecular Genetics|August 1, 1994
Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndromeW Reik, K W Brown, R E Slatter, et al.
Free Radical Research Communications|January 1, 1987
The effect of systemic heparinisation and haemodialysis on plasma octadeca-9,11-dienoic acid (9,11-LA')D G Wickens, J F Griffin, E R Maher, et al.
Human Molecular Genetics|December 1, 1995
Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domainW Reik, K W Brown, H Schneid, et al.
American Journal of Human Genetics|October 3, 1998
An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effectsA R Webster, F M Richards, F E MacRonald, et al.
Genes, Chromosomes & Cancer|June 13, 1998
Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesisS C Clifford, A H Prowse, N A Affara, et al.
Ophthalmology|March 18, 1999
A clinical and molecular genetic analysis of solitary ocular angiomaA R Webster, E R Maher, A C Bird, et al.
Journal of Medical Genetics|August 3, 2000
Detailed mapping of a congenital heart disease gene in chromosome 3p25E K Green, M D Priestley, J Waters, et al.
Pageof 18